Correlation Between VentriPoint Diagnostics and BMO Aggregate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and BMO Aggregate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and BMO Aggregate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VentriPoint Diagnostics and BMO Aggregate Bond, you can compare the effects of market volatilities on VentriPoint Diagnostics and BMO Aggregate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of BMO Aggregate. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and BMO Aggregate.

Diversification Opportunities for VentriPoint Diagnostics and BMO Aggregate

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between VentriPoint and BMO is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and BMO Aggregate Bond in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BMO Aggregate Bond and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with BMO Aggregate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BMO Aggregate Bond has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and BMO Aggregate go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and BMO Aggregate

Assuming the 90 days horizon VentriPoint Diagnostics is expected to under-perform the BMO Aggregate. In addition to that, VentriPoint Diagnostics is 13.84 times more volatile than BMO Aggregate Bond. It trades about -0.08 of its total potential returns per unit of risk. BMO Aggregate Bond is currently generating about 0.1 per unit of volatility. If you would invest  3,014  in BMO Aggregate Bond on August 28, 2024 and sell it today you would earn a total of  15.00  from holding BMO Aggregate Bond or generate 0.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

VentriPoint Diagnostics  vs.  BMO Aggregate Bond

 Performance 
       Timeline  
VentriPoint Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
BMO Aggregate Bond 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BMO Aggregate Bond has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BMO Aggregate is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

VentriPoint Diagnostics and BMO Aggregate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VentriPoint Diagnostics and BMO Aggregate

The main advantage of trading using opposite VentriPoint Diagnostics and BMO Aggregate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, BMO Aggregate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BMO Aggregate will offset losses from the drop in BMO Aggregate's long position.
The idea behind VentriPoint Diagnostics and BMO Aggregate Bond pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world